Johnson & Johnson Is the Latest FDA Casualty [View article]
Huang Thomas. While some oversight might be needed do you want Richard Pazdur at the FDA making the decision if you have no viable treatment options?
The FDA admittedly does not know how to properly evaluate innovative new treatments. Worse still they ignore their exper AC panels who do know how to do it.
Nobody at the top of this FDA has any humanity and nobody cares enough to do a proper risk/benefit analysis that properly reflects the risks to late stage prostate cancer patients.
That is why the FDA must listen more to advocates, less to big pharma and timely decide citizen petitions (not to mention respond to FOIA requests). The FDA works for us not big pharma. Litttle biotechs like Dendreon are threats to them, especially when they refuse to sell out to them.
Provenge wil be approved in 2010 but it is those that are missing out now that are the current victims of the inhumane FDA.
-
Huang Thomas. While some oversight might be needed do you want Richard Pazdur at the FDA making the decision if you have no viable treatment options?
Nov 28 09:02 am
|Rating:
0
0
All Comments by inhumane fda »Johnson & Johnson Is the Latest FDA Casualty [View article]
The FDA admittedly does not know how to properly evaluate innovative new treatments. Worse still they ignore their exper AC panels who do know how to do it.
Nobody at the top of this FDA has any humanity and nobody cares enough to do a proper risk/benefit analysis that properly reflects the risks to late stage prostate cancer patients.
That is why the FDA must listen more to advocates, less to big pharma and timely decide citizen petitions (not to mention respond to FOIA requests). The FDA works for us not big pharma. Litttle biotechs like Dendreon are threats to them, especially when they refuse to sell out to them.
Provenge wil be approved in 2010 but it is those that are missing out now that are the current victims of the inhumane FDA.